Momelotinib (MMB) Long-Term Safety: Pooled Data from Three Phase 3 Randomized-Controlled Trials (RCTs)

被引：1

作者：

Verstovsek, Srdan ^{[1
]}

Mesa, Ruben ^{[2
]}

Gupta, Vikas ^{[3
]}

Lavie, David ^{[4
]}

Dubruille, Viviane ^{[5
]}

Cambier, Nathalie ^{[6
]}

Platzbecker, Uwe ^{[7
]}

Hus, Marek ^{[8
]}

Xicoy, Blanca ^{[9
]}

Oh, Stephen T. ^{[10
]}

Kiladjian, Jean-Jacques ^{[11
]}

Vannucchi, Alessandro M. ^{[12
]}

Gerds, Aaron T. ^{[13
]}

Egyed, Miklos ^{[14
]}

Mayer, Jiri ^{[15
,16
]}

Sacha, Tomasz ^{[17
]}

Kawashima, Jun ^{[18
]}

Morris, Marc ^{[18
]}

Huang, Mei ^{[18
]}

Harrison, Claire ^{[19
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA

[2] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA

[3] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada

[4] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel

[5] Nantes Univ Hosp, Hematol Dept, Nantes, France

[6] Hosp St Vincent Paul GHICL Lille, Lille, France

[7] Univ Leipzig, Dept Hematol Cell Therapy & Hemostaseol, Med Ctr, Leipzig, Germany

[8] Med Univ Lublin, Lublin, Poland

[9] Univ Autanoma Barcelona, Barcelona, Spain

[10] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA

[11] Univ Paris, Hop St Louis, AP HP, Ctr Invest Clin, Paris, France

[12] Univ Florence, Florence, Italy

[13] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA

[14] Som Cty Mr Kaposi Gen Hosp, Kaposver, Hungary

[15] Masaryk Univ, Brno, Czech Republic

[16] Univ Hosp Brno, Brno, Czech Republic

[17] Jagiellonian Univ Hosp, Krakow, Poland

[18] Sierra Oncol Inc, San Mateo, CA USA

[19] Guys & St ThomasNHS Fdn Trust, London, England

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-162543

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9670 / 9672

页数：3

共 50 条

[1] Pooled long-term safety data from three phase 3 randomised controlled trials (RCTs) of momelotinib (MMB)
Harrison, Claire
Mesa, Ruben
Gupta, Vikas
Lavie, David
Dubruille, Viviane
Cambier, Nathalie
Platzbecker, Uwe
Hus, Marek
Xicoy, Blanca
Oh, Stephen
Kiladjian, Jean-Jacques
Vannucchi, Alessandro
Gerds, Aaron
Egyed, Miklos
Mayer, Jiri
Sacha, Tomasz
Kawashima, Jun
Morris, Marc
Huang, Mei
Verstovsek, Srdan
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 165 - 166
[2] Pooled long-term safety data from three phase 3 randomised controlled trials (RCTs) of momelotinib (MMB)
Harrison, Claire
Mesa, Ruben
Gupta, Vikas
Lavie, David
Dubruille, Viviane
Cambier, Nathalie
Platzbecker, Uwe
Hus, Marek
Xicoy, Blanca
Oh, Stephen
Kiladjian, Jean-Jacques
Vannucchi, Alessandro
Gerds, Aaron
Egyed, Miklos
Mayer, Jiri
Sacha, Tomasz
Kawashima, Jun
Morris, Marc
Huang, Mei
Verstovsek, Srdan
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 165 - 166
[3] Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
Verstovsek, Srdan
Mesa, Ruben
Gupta, Vikas
Lavie, David
Dubruille, Viviane
Cambier, Nathalie
Platzbecker, Uwe
Hus, Marek
Xicoy, Blanca
Oh, Stephen T.
Kiladjian, Jean-Jacques
Vannucchi, Alessandro M.
Gerds, Aaron
Egyed, Miklos
Mayer, Jiri
Sacha, Tomasz
Kawashima, Jun
Morris, Marc
Huang, Mei
Harrison, Claire
BLOOD ADVANCES, 2023, 7 (14) : 3582 - 3591
[4] Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
Mease, Philip J.
Gladman, Dafna D.
Gomez-Reino, Juan J.
Hall, Stephen
Kavanaugh, Arthur
Lespessailles, Eric
Schett, Georg
Paris, Maria
Delev, Nikolay
Teng, Lichen
Wollenhaupt, Juergen
ACR OPEN RHEUMATOLOGY, 2020, 2 (08) : 459 - 470
[5] Long-term safety and tolerability of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: pooled safety analysis of three phase 3, randomized controlled trials
Adebajo, A.
Mease, P.
Kavanaugh, A.
Gladman, D.
Gomez-Reino, J.
Wollenhaupt, J.
Cutolo, M.
Schett, G.
Lespessailles, E.
Shah, K.
Hu, C. C.
Stevens, R.
Edwards, C.
Birbara, C.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 68 - 69
[6] Long-Term Safety and Tolerability Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis: Pooled Safety Analysis Of Three Phase 3, Randomized, Controlled Trials
Mease, Philip J.
Kavanaugh, Arthur
Gladman, Dafna D.
Adebajo, Adewale O.
Gomez-Reino, Juan J.
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
Shah, Kamal
Hu, ChiaChi
Stevens, Randall M.
Edwards, Christopher J.
Birbara, Charles A.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S131 - S132
[7] Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials
Mease, Philip
Kavanaugh, Arthur
Gladman, Dafna
Adebajo, Adewale
Gomez-Reino, Juan
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
Shah, Kamal
Hu, ChiaChi
Stevens, Randall
Edwards, Christopher
Birbara, Charles
JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1551 - 1552
[8] LONG-TERM SAFETY AND TOLERABILITY OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS
Mease, P. J.
Kavanaugh, A.
Gladman, D.
Adebajo, A. O.
Gomez-Reino, J. J.
Wollenhaupt, J.
Cutolo, M.
Schett, G.
Lespessailles, E.
Shah, K.
Hu, C.
Stevens, R.
Edwards, C.
Birbara, C.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 742 - 743
[9] Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis of two phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Reich, K.
Papp, K.
Gordon, K.
Griffiths, C.
Chimenti, S.
Lopez-Estebaranz, J. L.
Gottlieb, A.
Shah, K.
Hu, C. C.
Day, R.
Paul, C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 138 - 139
[10] Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Crowley, Jeffrey
Thaci, Diamant
Joly, Pascal
Peris, Ketty
Papp, Kim A.
Goncalves, Joana
Day, Robert M.
Chen, Rongdean
Shah, Kamal
Ferrandiz, Carlos
Cather, Jennifer C.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 310 - +

← 1 2 3 4 5 →